Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Hose

Showing results (21-30 of 189) with videos related to

Pageof 19
Sort By:
BMC Genomics|December 21, 2017
A tissue-based approach to selection of reference genes for quantitative real-time PCR in a sheep osteoporosis modelFelix Schulze, Deeksha Malhan, Thaqif El Khassawna, et al.
Blood|November 25, 2010
Osteoclast-gene expression profiling reveals osteoclast-derived CCR2 chemokines promoting myeloma cell migrationJerome Moreaux, Dirk Hose, Alboukadel Kassambara, et al.
Cell Cycle (Georgetown, Tex.)|May 28, 2016
Forced KLF4 expression increases the generation of mature plasma cells and uncovers a network linked with plasma cell stageMatthieu Schoenhals, Michel Jourdan, Anja Seckinger, et al.
Plos One|August 4, 2012
Identification of pluripotent and adult stem cell genes unrelated to cell cycle and associated with poor prognosis in multiple myelomaAlboukadel Kassambara, Dirk Hose, Jérôme Moreaux, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2014
PET/CT studies of multiple myeloma using (18) F-FDG and (18) F-NaF: comparison of distribution patterns and tracers' pharmacokineticsChristos Sachpekidis, Hartmut Goldschmidt, Dirk Hose, et al.
Oncotarget|May 2, 2015
Massive parallel IGHV gene sequencing reveals a germinal center pathway in origins of human multiple myelomaGraeme Cowan, Nicola J Weston-Bell, Dean Bryant, et al.
Molecular Cancer Therapeutics|October 23, 2012
Development of gene expression-based score to predict sensitivity of multiple myeloma cells to DNA methylation inhibitorsJérôme Moreaux, Thierry Rème, Wim Leonard, et al.
Plos One|May 7, 2013
Inhibition of DEPDC1A, a bad prognostic marker in multiple myeloma, delays growth and induces mature plasma cell markers in malignant plasma cellsAlboukadel Kassambara, Matthieu Schoenhals, Jérôme Moreaux, et al.
Cancer Chemotherapy and Pharmacology|December 6, 2014
Cellular uptake kinetics of bortezomib in relation to efficacy in myeloma cells and the influence of drug transportersJannick Clemens, Anja Seckinger, Dirk Hose, et al.
Clinical Nuclear Medicine|March 19, 2015
(18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rateChristos Sachpekidis, Elias K Mai, Hartmut Goldschmidt, et al.
Pageof 19

Showing results (21-30 of 189) with videos related to

Sort By:
Pageof 19
BMC Genomics|December 21, 2017
A tissue-based approach to selection of reference genes for quantitative real-time PCR in a sheep osteoporosis modelFelix Schulze, Deeksha Malhan, Thaqif El Khassawna, et al.
Blood|November 25, 2010
Osteoclast-gene expression profiling reveals osteoclast-derived CCR2 chemokines promoting myeloma cell migrationJerome Moreaux, Dirk Hose, Alboukadel Kassambara, et al.
Cell Cycle (Georgetown, Tex.)|May 28, 2016
Forced KLF4 expression increases the generation of mature plasma cells and uncovers a network linked with plasma cell stageMatthieu Schoenhals, Michel Jourdan, Anja Seckinger, et al.
Plos One|August 4, 2012
Identification of pluripotent and adult stem cell genes unrelated to cell cycle and associated with poor prognosis in multiple myelomaAlboukadel Kassambara, Dirk Hose, Jérôme Moreaux, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2014
PET/CT studies of multiple myeloma using (18) F-FDG and (18) F-NaF: comparison of distribution patterns and tracers' pharmacokineticsChristos Sachpekidis, Hartmut Goldschmidt, Dirk Hose, et al.
Oncotarget|May 2, 2015
Massive parallel IGHV gene sequencing reveals a germinal center pathway in origins of human multiple myelomaGraeme Cowan, Nicola J Weston-Bell, Dean Bryant, et al.
Molecular Cancer Therapeutics|October 23, 2012
Development of gene expression-based score to predict sensitivity of multiple myeloma cells to DNA methylation inhibitorsJérôme Moreaux, Thierry Rème, Wim Leonard, et al.
Plos One|May 7, 2013
Inhibition of DEPDC1A, a bad prognostic marker in multiple myeloma, delays growth and induces mature plasma cell markers in malignant plasma cellsAlboukadel Kassambara, Matthieu Schoenhals, Jérôme Moreaux, et al.
Cancer Chemotherapy and Pharmacology|December 6, 2014
Cellular uptake kinetics of bortezomib in relation to efficacy in myeloma cells and the influence of drug transportersJannick Clemens, Anja Seckinger, Dirk Hose, et al.
Clinical Nuclear Medicine|March 19, 2015
(18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rateChristos Sachpekidis, Elias K Mai, Hartmut Goldschmidt, et al.
Pageof 19